Position in ICLR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$781,695
+$257,831 QoQ
Shares Held
4,500
-4.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#220
of 422 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Henshaw Capital LLC holds $41,281,054 across 2 Diagnostics & Research names. ICLR ranks #2 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
80,779 | $40,499,359 | |
| 2 | ICLR |
Icon PLC
This page
|
4,500 | $781,695 |
All Filings in ICLR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $781,695 | 4,500 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $523,864 | 4,734 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $862,629 | 4,734 | Shares | Sole | 2026-05-28 | |
| 2022-09-30 | $270,524 | 1,472 | Shares | Sole | 2026-05-28 | |
| 2022-06-30 | $318,982 | 1,472 | Shares | Sole | 2026-05-28 | |
| 2022-03-31 | $358,019 | 1,472 | Shares | Sole | 2026-05-28 | |
| 2021-12-31 | $709,213 | 2,290 | Shares | Sole | 2026-05-28 | |
| 2021-09-30 | $600,025 | 2,290 | Shares | Sole | 2026-05-28 | |
| 2021-06-30 | $473,365 | 2,290 | Shares | Sole | 2026-05-28 | |
| 2021-03-31 | $449,687 | 2,290 | Shares | Sole | 2026-05-28 | |
| 2020-12-31 | $319,182 | 1,637 | Shares | Sole | 2026-05-28 | |
| 2020-09-30 | $312,814 | 1,637 | Shares | Sole | 2026-05-28 | |
| 2020-06-30 | $275,769 | 1,637 | Shares | Sole | 2026-05-28 | |
| 2020-03-31 | $315,656 | 2,321 | Shares | Sole | 2026-05-28 | |
| No filing history on record for this holder in this stock. | ||||||